Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
| ▸ | TERT | O14746 | 1/20 | 0.38 |
| ▸ | UCHL3 | P15374 | 1/20 | 0.38 |
| ▸ | AKT1 | P31749 | 1/20 | 0.38 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | MMP1 | P03956 | 1/20 | 0.34 |
| ▸ | MMP2 | P08253 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.33 |
| ▸ | SHBG | P04278 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | NAAA | Q02083 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3059510 | 0.86 | ACHE (0.41) | ACHETERTUCHL3AKT1MAPK14 | |
| SCHEMBL3070641 | 0.84 | ACHE (0.48) | ACHETERTUCHL3AKT1MAPK14 | |
| SCHEMBL3056539 | 0.83 | AKT1 (0.43) | ACHETERTUCHL3AKT1MAPK14 | |
| SCHEMBL11705645 | 0.82 | ACHE (0.48) | ACHETERTUCHL3AKT1MAPK14 | |
| Potassium Ion SCHEMBL28287967 | 0.82 | ACHE (0.48) | ACHETERTUCHL3AKT1MAPK14 | |
| SCHEMBL11608393 | 0.82 | ACHE (0.48) | ACHETERTUCHL3AKT1MAPK14 | |
| SCHEMBL31474639 | 0.82 | ACHE (0.48) | ACHETERTUCHL3AKT1MAPK14 | |
| SCHEMBL3052282 | 0.82 | AKT1 (0.46) | ACHETERTUCHL3AKT1MAPK14 | |
| SCHEMBL3057529 | 0.80 | AKT1 (0.48) | ACHETERTUCHL3AKT1MAPK14 | |
| SCHEMBL11603446 | 0.80 | ACHE (0.45) | ACHETERTUCHL3AKT1MAPK14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2540761-B1 | CURABLE RESIN COMPOSITION | MITSUBISHI GAS CHEMICAL CO (JP) | 2016-08-31 | — | — | EP | disclosed |
| US-8853346-B2 | Curable resin composition | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2014-10-07 | — | — | US | disclosed |
| US-20130018168-A1 | CURABLE RESIN COMPOSITION | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2013-01-17 | — | — | US | disclosed |
| EP-2540761-A1 | CURABLE RESIN COMPOSITION | Mitsubishi Gas Chemical Company, Inc. (JP) | 2013-01-02 | — | — | EP | disclosed |
| US-20100267980-A1 | CURING ACCELERATOR FOR DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN, DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN COMPOSITION, AND DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN CURED PRODUCT | NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) | 2010-10-21 | — | — | US | disclosed |
| US-20090118442-A1 | CURING ACCELERATOR FOR DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN, DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN COMPOSITION, AND DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN CURED PRODUCT | NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) | 2009-05-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100267980-A1 | CURING ACCELERATOR FOR DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN, DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN COMPOSITION, AND DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN CURED PRODUCT | ELL, RAD54L, RPP30 | ACHE 3796/4885TERT 46/4885UCHL3 640/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.